These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Association of metabolic syndrome and patatin-like phospholipase 3 - rs738409 gene variant in non-alcoholic fatty liver disease among a Chennai-based south Indian population. Narayanasamy K; Karthick R; Panneerselvam P; Mohan N; Ramachandran A; Prakash R; Rajaram M J Gene Med; 2020 Apr; 22(4):e3160. PubMed ID: 31945251 [TBL] [Abstract][Full Text] [Related]
12. Salameh H; Hanayneh MA; Masadeh M; Naseemuddin M; Matin T; Erwin A; Singal AK J Clin Transl Hepatol; 2016 Sep; 4(3):175-191. PubMed ID: 27777887 [No Abstract] [Full Text] [Related]
13. Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients. Tai CM; Huang CK; Tu HP; Hwang JC; Yeh ML; Huang CF; Huang JF; Dai CY; Chuang WL; Yu ML Medicine (Baltimore); 2016 Mar; 95(12):e3120. PubMed ID: 27015186 [TBL] [Abstract][Full Text] [Related]
14. Role of the PNPLA3 I148M polymorphism in nonalcoholic fatty liver disease and fibrosis in Korea. Lee SS; Byoun YS; Jeong SH; Woo BH; Jang ES; Kim JW; Kim HY Dig Dis Sci; 2014 Dec; 59(12):2967-74. PubMed ID: 25069572 [TBL] [Abstract][Full Text] [Related]
15. Association of single nucleotide polymorphism at PNPLA3 with fatty liver, steatohepatitis, and cirrhosis of liver. Alam S; Islam MS; Islam S; Mustafa G; Saleh AA; Ahmad N Indian J Gastroenterol; 2017 Sep; 36(5):366-372. PubMed ID: 28975533 [TBL] [Abstract][Full Text] [Related]
16. Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis. Tang S; Zhang J; Mei TT; Guo HQ; Wei XH; Zhang WY; Liu YL; Liang S; Fan ZP; Ma LX; Lin W; Liu YR; Qiu LX; Yu HB BMC Med Genet; 2020 Aug; 21(1):163. PubMed ID: 32811452 [TBL] [Abstract][Full Text] [Related]
17. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population. Verrijken A; Beckers S; Francque S; Hilden H; Caron S; Zegers D; Ruppert M; Hubens G; Van Marck E; Michielsen P; Staels B; Taskinen MR; Van Hul W; Van Gaal L Obesity (Silver Spring); 2013 Oct; 21(10):2138-45. PubMed ID: 23512881 [TBL] [Abstract][Full Text] [Related]
18. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population. Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980 [TBL] [Abstract][Full Text] [Related]
19. Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome. Stättermayer AF; Traussnigg S; Aigner E; Kienbacher C; Huber-Schönauer U; Steindl-Munda P; Stadlmayr A; Wrba F; Trauner M; Datz C; Ferenci P J Trace Elem Med Biol; 2017 Jan; 39():100-107. PubMed ID: 27908400 [TBL] [Abstract][Full Text] [Related]